Your browser doesn't support javascript.
loading
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA.
Capoferri, Adam A; Wiegand, Ann; Hong, Feiyu; Jacobs, Jana L; Spindler, Jonathan; Musick, Andrew; Bale, Michael J; Shao, Wei; Sobolewski, Michele D; Cillo, Anthony R; Luke, Brian T; Fennessey, Christine M; Gorelick, Robert J; Hoh, Rebecca; Halvas, Elias K; Deeks, Steven G; Coffin, John M; Mellors, John W; Kearney, Mary F.
Afiliación
  • Capoferri AA; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702.
  • Wiegand A; Department of Microbiology and Immunology, Georgetown University, Washington, DC 20007.
  • Hong F; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702.
  • Jacobs JL; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
  • Spindler J; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
  • Musick A; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702.
  • Bale MJ; Leidos Biomedical Research, Inc., Frederick National Laboratories for Cancer Research, Frederick, MD 21702.
  • Shao W; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702.
  • Sobolewski MD; Laboratory of Epigenetics and Immunity, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065.
  • Cillo AR; Leidos Biomedical Research, Inc., Frederick National Laboratories for Cancer Research, Frederick, MD 21702.
  • Luke BT; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
  • Fennessey CM; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.
  • Gorelick RJ; Leidos Biomedical Research, Inc., Frederick National Laboratories for Cancer Research, Frederick, MD 21702.
  • Hoh R; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
  • Halvas EK; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
  • Deeks SG; Department of Medicine, University of California, San Francisco, CA 94143.
  • Coffin JM; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
  • Mellors JW; Department of Medicine, University of California, San Francisco, CA 94143.
  • Kearney MF; Department of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111.
Proc Natl Acad Sci U S A ; 121(36): e2405210121, 2024 Sep 03.
Article en En | MEDLINE | ID: mdl-39190360
ABSTRACT
In the absence of antiretroviral therapy (ART), a subset of individuals, termed HIV controllers, have levels of plasma viremia that are orders of magnitude lower than non-controllers (NC) who are at higher risk for HIV disease progression. In addition to having fewer infected cells resulting in fewer cells with HIV RNA, it is possible that lower levels of plasma viremia in controllers are due to a lower fraction of the infected cells having HIV-1 unspliced RNA (HIV usRNA) compared with NC. To directly test this possibility, we used sensitive and quantitative single-cell sequencing methods to compare the fraction of infected cells that contain one or more copies of HIV usRNA in peripheral blood mononuclear cells (PBMC) obtained from controllers and NC. The fraction of infected cells containing HIV usRNA did not differ between the two groups. Rather, the levels of viremia were strongly associated with the total number of infected cells that had HIV usRNA, as reported by others, with controllers having 34-fold fewer infected cells per million PBMC. These results reveal that viremic control is not associated with a lower fraction of proviruses expressing HIV usRNA, unlike what is reported for elite controllers, but is only related to having fewer infected cells overall, maybe reflecting greater immune clearance of infected cells. Our findings show that proviral silencing is not a key mechanism for viremic control and will help to refine strategies toward achieving HIV remission without ART.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Viremia / ARN Viral / Leucocitos Mononucleares / Infecciones por VIH / VIH-1 Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Viremia / ARN Viral / Leucocitos Mononucleares / Infecciones por VIH / VIH-1 Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos